Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells

1,689 views

|

March 3, 2016

The chromium release assay, a common assay for detecting cytotoxic T cell activity, has several limitations. Using antigen-specific CD8 T cells and the human breast cancer tumor line SKBR3, in the present article the xCELLigence real-time cell analysis instrument is examined for the capability of detecting cell killing. Results are directly compared with the traditional chromium-51 release assay.

For more information, please visit: http://www.aceabio.com/products/xcelligence-rtca/

References:
Erskine, C. L., Henle, A. M., Knutson, K. L. Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System. J. Vis. Exp. (66), e3683, doi:10.3791/3683 (2012).

Analytical TechniquesDrug DiscoveryImmunologyMolecular Biology

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.